562 Combined spatial and transcriptomic analysis identifies immune microenvironment factors associated with checkpoint inhibition response in triple negative breast cancer
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1827764984146296832 |
|---|---|
| author | Wei Han Matthew Loya Omar Jabado Patrick Franken Nora Pencheva Mark Fereshteh Chung-Wein Lee Clifton Drew Louise Koopman Angelo Harris Mohammed Qutaish Brooke Robertson |
| author_facet | Wei Han Matthew Loya Omar Jabado Patrick Franken Nora Pencheva Mark Fereshteh Chung-Wein Lee Clifton Drew Louise Koopman Angelo Harris Mohammed Qutaish Brooke Robertson |
| author_sort | Wei Han |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:12:40Z |
| format | Article |
| id | doaj.art-a1f43e7e503f4d43b6419599f2f2b8e2 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:12:40Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-a1f43e7e503f4d43b6419599f2f2b8e22023-11-11T14:00:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0562562 Combined spatial and transcriptomic analysis identifies immune microenvironment factors associated with checkpoint inhibition response in triple negative breast cancerWei Han0Matthew Loya1Omar Jabado2Patrick Franken3Nora Pencheva4Mark Fereshteh5Chung-Wein Lee6Clifton Drew7Louise Koopman8Angelo Harris9Mohammed Qutaish10Brooke Robertson11Department of General Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing, ChinaAff59 grid.239578.20000000106754725Lerner Research Institute, Cleveland Clinic Cleveland OH USAGenmab, Princeton, NJ, USAGenmab, Princeton, NJ, USA3Genmab, Utrecht, Netherlands2Genmab A/S, Utrecht, NetherlandsRakuten Medical, San Diego, CA, USA1Genmab, Princeton, NJ, USAGenmab, Utrecht, NetherlandsGenmab, Princeton, NJ, USAGenmab, Princeton, NJ, USA1Genmab, Princeton, NJ, USA |
| spellingShingle | Wei Han Matthew Loya Omar Jabado Patrick Franken Nora Pencheva Mark Fereshteh Chung-Wein Lee Clifton Drew Louise Koopman Angelo Harris Mohammed Qutaish Brooke Robertson 562 Combined spatial and transcriptomic analysis identifies immune microenvironment factors associated with checkpoint inhibition response in triple negative breast cancer Journal for ImmunoTherapy of Cancer |
| title | 562 Combined spatial and transcriptomic analysis identifies immune microenvironment factors associated with checkpoint inhibition response in triple negative breast cancer |
| title_full | 562 Combined spatial and transcriptomic analysis identifies immune microenvironment factors associated with checkpoint inhibition response in triple negative breast cancer |
| title_fullStr | 562 Combined spatial and transcriptomic analysis identifies immune microenvironment factors associated with checkpoint inhibition response in triple negative breast cancer |
| title_full_unstemmed | 562 Combined spatial and transcriptomic analysis identifies immune microenvironment factors associated with checkpoint inhibition response in triple negative breast cancer |
| title_short | 562 Combined spatial and transcriptomic analysis identifies immune microenvironment factors associated with checkpoint inhibition response in triple negative breast cancer |
| title_sort | 562 combined spatial and transcriptomic analysis identifies immune microenvironment factors associated with checkpoint inhibition response in triple negative breast cancer |
| work_keys_str_mv | AT weihan 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer AT matthewloya 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer AT omarjabado 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer AT patrickfranken 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer AT norapencheva 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer AT markfereshteh 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer AT chungweinlee 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer AT cliftondrew 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer AT louisekoopman 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer AT angeloharris 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer AT mohammedqutaish 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer AT brookerobertson 562combinedspatialandtranscriptomicanalysisidentifiesimmunemicroenvironmentfactorsassociatedwithcheckpointinhibitionresponseintriplenegativebreastcancer |